Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LYC-55716 |
Trade Name | |
Synonyms | Cintirorgon|LYC55716 |
Drug Descriptions |
Cintirorgon (LYC-55716) is a retinoic acid-related orphan receptor gamma agonist, which may increase T-cell mediated anti-tumor immune response, potentially leading to inhibition of tumor growth (AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 5566, PMID: 30819679). |
DrugClasses | |
CAS Registry Number | 2055536-64-4 |
NCIT ID | C131294 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LYC-55716 | LYC-55716 | 0 | 1 |
LYC-55716 + Pembrolizumab | LYC-55716 Pembrolizumab | 0 | 1 |